ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

OGN Organon and Co

20.79
1.18 (6.02%)
取引時間後
最終更新日: 07:27:19
15分遅延
名称 銘柄コード 市場 種別
Organon and Co OGN NYSE 普通株式
  前日比 前日比 % 現在値 時刻
1.18 6.02% 20.79 07:27:19
始値 安値 高値 終値 前日終値
19.75 19.59 20.79 20.68 19.61
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0220:30BWOrganon Reports Results for the First Quarter Ended March..
2024/4/0921:13BWProlia ® とXgeva ®..
2024/4/0903:31BWL'essai clinique comparatif de phase 3 du candidat..
2024/4/0819:15BWOrganon To Report First Quarter 2024 Results and Host..
2024/4/0819:00BWPhase 3 Comparative Clinical Study of Prolia® and Xgeva®..
2024/3/0823:01PRNCAOn International Women's Day, Organon Canada is encouraging..
2024/3/0206:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0206:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0206:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0206:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2622:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2022:00BWOrganon Announces HADLIMA™ (adalimumab-bwwd) Has Been..
2024/2/1521:48EDGAR2Form 8-K - Current report
2024/2/1521:30BWOrganon Reports Results for the Fourth Quarter and Full Year..
2024/2/1406:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0121:30BWOrganon To Report Fourth Quarter and Full Year Results and..
2024/1/1021:33BWOrganon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2%..
2024/1/0821:30BWOrganon affirms 2023 revenue and Adjusted EBITDA guidance..
2023/12/2121:30BWOrganon To Present at the 42nd Annual J.P. Morgan Healthcare..
2023/12/1922:30BWOrganon et Lilly concluent un accord de commercialisation en..
2023/12/1918:11BWOrganon と Lilly、ヨーロッパで 2 種類の片頭痛薬商業化契約を締結
2023/12/1911:26BWOrganon und Lilly schließen Vermarktungsvereinbarung für..
2023/12/1821:30BWOrganon & Lilly Enter Commercialization Agreement in Europe..
2023/12/0606:31EDGAR2Form 8-K - Current report
2023/11/2121:30BWOrganon To Present at the Piper Sandler 35th Annual..
2023/11/0806:15GLOBESamsung Bioepis & Organon Announce FDA Acceptance of..
2023/11/0320:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0220:38EDGAR2Form 8-K - Current report
2023/11/0220:30BWOrganon Reports Results for the Third Quarter Ended..
2023/11/0120:30BWOrganon and Sempre Health Announce Collaboration on New..
2023/10/2620:00PRNCAOrganon Canada annonce la disponibilité d'une préparation..
2023/10/1920:30BWOrganon To Report Third Quarter Results and Host Conference..
2023/10/1407:02PRNUSLululemon Athletica & Hubbell Set to Join S&P 500; Others to..
2023/9/2804:13BWOrganon figure sur la liste « Change the World » de Fortune..
2023/9/2802:43BWオルガノン、フォーチュン誌の2023年チェンジ・ザ・ワールドリストで避妊の選択肢へのアクセスを拡大するリーダーシップで表彰される
2023/9/2802:33BWOrganon auf der Fortune „Change the World“-Liste 2023 für..
2023/9/2720:30BWOrganon Recognized on Fortune’s 2023 Change the World List..
2023/9/2620:01PRNCAOn World Contraception Day, Organon Canada Declares Support..
2023/9/1506:12BWFirst Real-World Observational Study of the JADA® System, a..
2023/9/0608:38BWオルガノン、2人のリーダー任命で研究開発の専門知識を強化
2023/9/0605:27BWOrganon renforce ses capacités de recherche et de..
2023/9/0602:52BWOrganon stärkt Forschungs- und Entwicklungskompetenz mit..
2023/9/0523:00BWOrganon Bolsters Research & Development Expertise with Two..
2023/8/0921:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0820:58EDGAR2Form 8-K - Current report
2023/8/0820:30BWOrganon Reports Results for the Second Quarter Ended June..
2023/8/0120:00GLOBESamsung Bioepis & Organon Announce Topline Results from..
2023/7/1720:30BWOrganon To Report Second Quarter Results and Host Conference..
2023/7/0805:05EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock